Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A I Faden

Showing results (1-10 of 257) with videos related to

Pageof 26
Sort By:
Central Nervous System Trauma : Journal of the American Paralysis Association|January 1, 1987
Opiate-receptor antagonists, thyrotropin-releasing hormone (TRH), and TRH analogs in the treatment of spinal cord injuryA I Faden
Stroke|March 1, 1983
Neuropeptides and stroke: current status and potential applicationA I Faden
Archives of Neurology|May 1, 1986
Neuropeptides and central nervous system injury. Clinical implicationsA I Faden
Brain Research|May 8, 1989
TRH analog YM-14673 improves outcome following traumatic brain and spinal cord injury in rats: dose-response studiesA I Faden
Neurologic Clinics|March 28, 1998
Iatrogenic illness. An overview with particular reference to neurologic complicationsA I Faden
NIDA Research Monograph|January 1, 1996
Neurotoxic versus neuroprotective actions of endogenous opioid peptides: implications for treatment of CNS injuryA I Faden
Pharmacology & Toxicology|January 1, 1996
Pharmacological treatment of central nervous system traumaA I Faden
Archives of Neurology|October 27, 2001
Neuroprotection and traumatic brain injury: the search continuesA I Faden
The Journal of the American Osteopathic Association|September 1, 1984
Endogenous opioids: physiologic and pathophysiologic actionsA I Faden
Stroke|May 1, 1984
Opiate antagonists in the treatment of strokeA I Faden
Pageof 26

Showing results (1-10 of 257) with videos related to

Sort By:
Pageof 26
Central Nervous System Trauma : Journal of the American Paralysis Association|January 1, 1987
Opiate-receptor antagonists, thyrotropin-releasing hormone (TRH), and TRH analogs in the treatment of spinal cord injuryA I Faden
Stroke|March 1, 1983
Neuropeptides and stroke: current status and potential applicationA I Faden
Archives of Neurology|May 1, 1986
Neuropeptides and central nervous system injury. Clinical implicationsA I Faden
Brain Research|May 8, 1989
TRH analog YM-14673 improves outcome following traumatic brain and spinal cord injury in rats: dose-response studiesA I Faden
Neurologic Clinics|March 28, 1998
Iatrogenic illness. An overview with particular reference to neurologic complicationsA I Faden
NIDA Research Monograph|January 1, 1996
Neurotoxic versus neuroprotective actions of endogenous opioid peptides: implications for treatment of CNS injuryA I Faden
Pharmacology & Toxicology|January 1, 1996
Pharmacological treatment of central nervous system traumaA I Faden
Archives of Neurology|October 27, 2001
Neuroprotection and traumatic brain injury: the search continuesA I Faden
The Journal of the American Osteopathic Association|September 1, 1984
Endogenous opioids: physiologic and pathophysiologic actionsA I Faden
Stroke|May 1, 1984
Opiate antagonists in the treatment of strokeA I Faden
Pageof 26